Recently, Olig2 was shown to behave as an oncogenic activator in Shh medulloblastoma (Shh-MB; Zhang et al., 2019), a malignant pediatric brain tumor characterized by activation of Shh signaling (Skowron et al., 2021). This evidence concerns the gene SHH and medulloblastoma.